Pipeline — registered trials by phase
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
— · Preeclampsia · Completed · est. 2017-11-20
Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
— · Post-natal Cytogenetics · Completed · est. 2011-11
Collection of Whole Blood Specimens in Pregnant Women
— · Pregnancy Related · Completed · est. 2019-08-30
Single Embryo TrAnsfeR of Euploid Embryo
— · Infertility, Aneuploidy · Completed · est. 2016-12-31
A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With Neuroblastoma
— · Neuroblastoma · Completed · est. 2026-07-30
NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology
— · Neurologic Deficits, Neurologic Disorder, Neurologic Abnormalities · Completed · est. 2024-01-31
Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA
— · Detection and Genotyping of Factor V and Factor II Point Mutations · Completed · est. 2009-09
Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
— · SARS-CoV-2 · Completed · est. 2021-02-28
Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel
— · SARS-CoV-2 · Completed · est. 2021-02-28
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
— · Pregnancy · Completed · est. 2019-12-30
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
— · Rare Diseases · Completed · est. 2019-04-30
No registered trials in this stage.
18F-mFBG Cardiac Uptake With Lewy Body Dementia
— · Parkinson Disease (PD), Lewy Body Dementia (LBD) · Recruiting · est. 2026-10-30
Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation
— · Cardiovascular Diseases · Active Not Recruiting · est. 2025-03-07
18F-mFBG Imaging for Myocardial Sympathetic Innervation
— · Heart Failure, Ischemic Cardiomyopathy, ICD Patients · Recruiting · est. 2026-10-30
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
— · Neuroblastoma · Completed · est. 2026-07-30
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Illumina is lead sponsor; 15 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G2026-10-07SCHEDULE 13G
- 8-K2026-08-17Current report (material event)
- 8-K2026-08-13Current report (material event)
- 424B22026-08-12424B2
- 8-K2026-08-12Current report (material event)
- FWP2026-08-10FWP
- 424B22026-08-10424B2
- 8-K2026-08-07Current report (material event)
- 10-Q2026-07-31Quarterly report
- 8-K2026-07-30Current report (material event)
- 8-K2026-06-23Current report (material event)
- 8-K2026-05-26Current report (material event)
- SD2026-05-19SD
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- 10-Q2026-05-04Quarterly report
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- ARS2026-04-09Annual report to holders
- DEFA14A2026-04-09DEFA14A
- DEF 14A2026-04-09Proxy statement
- 8-K2026-04-02Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- 10-K2026-02-12Annual report
- 8-K2026-02-05Current report (material event)
- 8-K2026-01-30Current report (material event)
- 8-K2026-01-13Current report (material event)
- 8-K2026-01-08Current report (material event)
- 8-K2025-11-25Current report (material event)
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
- 8-K2025-11-12Current report (material event)
- 424B22025-11-12424B2
- FWP2025-11-12FWP
- 424B22025-11-10424B2
- 10-Q2025-10-31Quarterly report
- 8-K2025-10-30Current report (material event)
- SCHEDULE 13G/A2025-08-13SCHEDULE 13G/A
- 10-Q2025-08-01Quarterly report
- 8-K2025-07-31Current report (material event)
- 8-K2025-06-23Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.